Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs KABRA DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA KABRA DRUGS AJANTA PHARMA/
KABRA DRUGS
 
P/E (TTM) x 38.3 -6.2 - View Chart
P/BV x 8.3 - - View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AJANTA PHARMA   KABRA DRUGS
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
KABRA DRUGS
Mar-23
AJANTA PHARMA/
KABRA DRUGS
5-Yr Chart
Click to enlarge
High Rs1,4266 25,014.0%   
Low Rs1,0623 36,006.8%   
Sales per share (Unadj.) Rs297.20-  
Earnings per share (Unadj.) Rs46.7-0.8 -6,065.3%  
Cash flow per share (Unadj.) Rs57.1-0.8 -7,414.5%  
Dividends per share (Unadj.) Rs7.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs269.1-1.7 -16,157.9%  
Shares outstanding (eoy) m125.914.39 2,868.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.20-  
Avg P/E ratio x26.6-5.6 -474.4%  
P/CF ratio (eoy) x21.8-5.6 -388.1%  
Price / Book Value ratio x4.6-2.6 -178.1%  
Dividend payout %15.00-   
Avg Mkt Cap Rs m156,63819 825,278.6%   
No. of employees `000NANA-   
Total wages/salary Rs m7,8512 338,422.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,4260-  
Other income Rs m9860 1,644,000.0%   
Total revenues Rs m38,4130 64,021,333.3%   
Gross profit Rs m7,833-3 -227,689.0%  
Depreciation Rs m1,3080-   
Interest Rs m580-   
Profit before tax Rs m7,453-3 -220,488.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5730-   
Profit after tax Rs m5,880-3 -173,958.6%  
Gross profit margin %20.90- 
Effective tax rate %21.10-   
Net profit margin %15.70- 
BALANCE SHEET DATA
Current assets Rs m28,2527 415,467.6%   
Current liabilities Rs m11,39314 79,392.3%   
Net working cap to sales %45.00- 
Current ratio x2.50.5 523.3%  
Inventory Days Days660- 
Debtors Days Days100- 
Net fixed assets Rs m18,7070 8,133,260.9%   
Share capital Rs m25344 575.8%   
"Free" reserves Rs m33,624-51 -65,671.5%   
Net worth Rs m33,877-7 -463,426.8%   
Long term debt Rs m130-   
Total assets Rs m47,0477 668,274.1%  
Interest coverage x128.60-  
Debt to equity ratio x00-  
Sales to assets ratio x0.80-   
Return on assets %12.6-48.0 -26.3%  
Return on equity %17.446.2 37.5%  
Return on capital %22.246.2 48.0%  
Exports to sales %59.90-  
Imports to sales %11.50-  
Exports (fob) Rs m22,420NA-   
Imports (cif) Rs m4,293NA-   
Fx inflow Rs m22,4200-   
Fx outflow Rs m4,2930-   
Net fx Rs m18,1270-   
CASH FLOW
From Operations Rs m7,918-4 -223,666.7%  
From Investments Rs m-5,596NA-  
From Financial Activity Rs m-1,0794 -30,300.6%  
Net Cashflow Rs m1,2430 6,215,500.0%  

Share Holding

Indian Promoters % 66.2 0.0 -  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.8 0.0 -  
FIIs % 9.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 100.0 33.8%  
Shareholders   54,351 7,396 734.9%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs KABRA DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs KABRA DRUGS Share Price Performance

Period AJANTA PHARMA KABRA DRUGS S&P BSE HEALTHCARE
1-Day 2.51% 0.00% 1.18%
1-Month 7.60% 4.96% -0.75%
1-Year 92.91% 29.08% 61.82%
3-Year CAGR 21.63% 18.78% 18.16%
5-Year CAGR 26.85% 67.83% 19.79%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the KABRA DRUGS share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of KABRA DRUGS the stake stands at 0.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of KABRA DRUGS.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

KABRA DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of KABRA DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.